Comprehensive pain therapy for dorsopathies: the role of neurotropic vitamins of group B | Ukrainian Medical Journal

Dorsopathies are one of the most common causes of chronic pain and reduced work capacity. In a significant part of patients, pain has a mixed nociceptive-neuropathic nature, which requires a comprehensive approach to treatment. The article summarizes current data on the role of neurotropic vitamins of group B (thiamine, pyridoxine and cobalamin) in the management of pain syndrome in dorsopathies. The mechanisms of their neurometabolic, anti-inflammatory and neuroprotective action are considered, and clinical data on the effectiveness of combined use with non-steroidal anti-inflammatory drugs are also presented. Practical approaches to the phased use of neurotropic vitamins in the complex therapy of dorsopathies are presented.

References

1. GBD 2021 Low Back Pain Collaborators (2023) Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol., 5(6): e316–e329. doi.org/10.1016/S2665-9913(23)00098-X.
2. Foster N.E., Anema J.R., Cherkin D. et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018; 391(10137): 2368–2383.
3. Briggs A.M., Sumi Y., Banerjee A. (2025) The World Health Organization guideline for non-surgical management of chronic primary low back pain in adults: Implications for equitable care and strengthening health systems globally. Global Health Research and Policy, 10(1): 26. doi.org/10.1186/s41256-025-00426-w.
4. Chiarotto A., Koes B.W. (2022) Nonspecific Low Back Pain. New Engl. J. Med., 386(18): 1732–1740. doi.org/10.1056/nejmcp2032396.
5. Maher C., Underwood M., Buchbinder R. (2017) Non-specific low back pain. The Lancet, 389(10070): 736–747.
6. Hartvigsen J., Hancock M.J., Kongsted A. et al. (2018) What low back pain is and why we need to pay attention. The Lancet, 391(10137): 2356–2367.
7. Calderon-Ospina C.A., Nava-Mesa M.O., Arbeláez Ariza C.E. (2020) Effect of combined diclofenac and B vitamins for low back pain management: Systematic review and meta-analysis. Pain Med., 21(4): 766–781. doi.org/10.1093/pm/pnz216.
8. DePalma M.G. (2020) Red flags of low back pain. JAAPA, 33(8): 8–11.
9. Chiarotto A., Boers M., Deyo R.A. et al. (2018) Core outcome measurement instruments for clinical trials in nonspecific low back pain. Pain, 159(3): 481–495.
10. Roland M., Morris R. (1983) A study of the natural history of back pain. Part I: Development of a reliable and sensitive measure of disability in low-back pain. Spine, 8(2): 141–144. doi.org/10.1097/00007632-198303000-00004.
11. Low back pain and sciatica in over 16s: assessment and management. London: National Institute for Health and Care Excellence (NICE). 2020 (NICE Guideline No. 59).
12. Pinzon R.T., Schellack N., Matawaran B.J. et al. (2023) Clinical recommendations for the use of neurotropic B vitamins (B1, B6, and B12) for the management of peripheral neuropathy. J. Assoc. Phys. India, 71(7): 11–12. doi.org/10.59556/japi.71.0290.
13. Rakić M., Lunić T., Bekić M. et al. (2023) Vitamin B complex suppresses neuroinflammation in activated microglia: In vitro and in silico approach combined with dynamical modeling. Int. Immunopharmacol., 121: 110525.
14. Nava-Mesa M.O., Aispuru Lanche G.R. (2021) Role of B vitamins, thiamine, pyridoxine, and cyanocobalamin in back pain and other musculoskeletal conditions: A narrative review. SEMERGEN, 47(8): 551–562.
15. Delgado-García P., Alcocer-Herrera J.B., Urenda-Quezada A. et al. (2024) A randomized control trial of dexketoprofen/vitamin B (thiamine, pyridoxine and cyanocobalamin) fixed-dose combination in post-traumatic grade I–II cervical sprains. Clin. Drug Invest., 44(6): 413–424. doi.org/10.1007/s40261-024-01370-2.
16. Geller M., Mibielli M.A., Nunes C.P. et al. (2016) Comparison of the action of diclofenac alone versus diclofenac plus B vitamins on mobility in patients with low back pain. J. Drug Assess., 5(1): 1–3. doi.org/10.3109/21556660.2016.1163263.
17. Milgamma^® (Мільгама^®) compendium.com.ua/dec/557001.